JP2021515789A5 - - Google Patents

Info

Publication number
JP2021515789A5
JP2021515789A5 JP2020548696A JP2020548696A JP2021515789A5 JP 2021515789 A5 JP2021515789 A5 JP 2021515789A5 JP 2020548696 A JP2020548696 A JP 2020548696A JP 2020548696 A JP2020548696 A JP 2020548696A JP 2021515789 A5 JP2021515789 A5 JP 2021515789A5
Authority
JP
Japan
Prior art keywords
treatment system
activator
silicone
transdermal treatment
acrylic hybrid
Prior art date
Application number
JP2020548696A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019175101A5 (https=
JP2021515789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/056016 external-priority patent/WO2019175101A1/en
Publication of JP2021515789A publication Critical patent/JP2021515789A/ja
Publication of JPWO2019175101A5 publication Critical patent/JPWO2019175101A5/ja
Publication of JP2021515789A5 publication Critical patent/JP2021515789A5/ja
Abandoned legal-status Critical Current

Links

JP2020548696A 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム Abandoned JP2021515789A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161432.2 2018-03-13
EP18161432 2018-03-13
PCT/EP2019/056016 WO2019175101A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer

Publications (3)

Publication Number Publication Date
JP2021515789A JP2021515789A (ja) 2021-06-24
JPWO2019175101A5 JPWO2019175101A5 (https=) 2022-03-22
JP2021515789A5 true JP2021515789A5 (https=) 2022-03-22

Family

ID=61628186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020548696A Abandoned JP2021515789A (ja) 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム

Country Status (7)

Country Link
US (1) US20210000756A1 (https=)
EP (1) EP3764996A1 (https=)
JP (1) JP2021515789A (https=)
CN (1) CN111867569A (https=)
BR (1) BR112020018607A2 (https=)
CA (1) CA3092775A1 (https=)
WO (1) WO2019175101A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3079694A1 (en) 2017-10-11 2019-04-18 Dow Silicones Corporation Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone acrylic hybrid polymer
CN111447926B (zh) 2017-10-11 2024-04-30 罗曼治疗系统股份公司 用于透皮施用胍法辛的包含至少一种添加剂的透皮治疗系统

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6974588B1 (en) * 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
EP2024406B1 (en) 2006-06-06 2012-08-01 Dow Corning Corporation A silicone acrylate hybrid composition
BRPI1014886B1 (pt) 2009-04-24 2020-02-11 Henkel IP & Holding GmbH Polímeros acrílicos de silicone híbridos, seus métodos de preparação, adesivos e soluções de uma composição adesiva sensível à pressão compreendendo os mesmos.
JP2013139554A (ja) * 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
TW201338813A (zh) 2011-12-12 2013-10-01 洛曼治療系統股份有限公司 經皮遞送系統
AU2013205080B2 (en) * 2012-12-12 2016-07-07 Lts Lohmann Therapie-Systeme Ag Transdermal Delivery System
US10316228B2 (en) 2015-02-09 2019-06-11 Dow Silicones Corporation Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same
US20170112781A1 (en) * 2015-10-27 2017-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems with polyisobutylene face adhesive
KR102381686B1 (ko) * 2016-07-22 2022-04-01 에르테에스 로만 테라피-시스테메 아게 접착제 도메인의 제어

Similar Documents

Publication Publication Date Title
AU2016215180B2 (en) Pressure-sensitive adhesives for transdermal drug delivery
JPH0474329B2 (https=)
WO2014062494A1 (en) Compositions and methods for the transdermal delivery of methylphenidate
US5260064A (en) Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
JPH0725669B2 (ja) 経皮投与用医薬製剤
JPS60185713A (ja) 経皮吸収性製剤及びその製法
JP2021515789A5 (https=)
JP2021517572A5 (https=)
EP0285550A2 (en) A percutaneous-administration-type pharmaceutical preparation of nitroglycerin
JPWO2019175101A5 (https=)
JPWO2019175109A5 (https=)
JP2021515791A5 (https=)
JP2021522187A5 (https=)
CN111867569A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
CN111971032A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
JPWO2019175106A5 (https=)
JP2021517569A5 (https=)
JP4255536B2 (ja) 新規貼付剤
JPWO2019201755A5 (https=)
JP3233705B2 (ja) 貼付剤
JP2697191B2 (ja) 経皮吸収製剤
JPS5835113A (ja) 複合製剤
JPH06239753A (ja) 抗血栓経皮吸収製剤
CA2934924C (en) Compositions and methods for transdermal delivery of amphetamine
JP4617069B2 (ja) 貼付剤